PubRank

Donald D Price

Author PubWeight™ 96.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002 3.17
2 Racial/ethnic differences in the experience of chronic pain. Pain 2002 2.40
3 The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003 2.33
4 A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst 2007 2.18
5 Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. Pain 2008 1.98
6 Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003 1.89
7 Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003 1.87
8 Individual differences in pain sensitivity: genetic and environmental contributions. Pain 2007 1.77
9 Pain measurement and brain activity: will neuroimages replace pain ratings? J Pain 2013 1.76
10 Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003 1.74
11 Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003 1.71
12 Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005 1.68
13 Gender role expectations of pain: relationship to experimental pain perception. Pain 2002 1.56
14 Spatial summation of mechanically evoked muscle pain and painful aftersensations in normal subjects and fibromyalgia patients. Pain 2007 1.56
15 Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 2009 1.55
16 Placebo-induced analgesia in an operant pain model in rats. Pain 2012 1.55
17 Influences of gender role and anxiety on sex differences in temporal summation of pain. J Pain 2004 1.55
18 Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007 1.51
19 Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia. Neuroimage 2007 1.48
20 Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain 2005 1.47
21 Individual differences in pain sensitivity: measurement, causation, and consequences. J Pain 2009 1.45
22 Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003 1.44
23 Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 2005 1.40
24 Do hypnotic analgesic interventions contain placebo effects? Pain 2006 1.39
25 Brain activity related to temporal summation of C-fiber evoked pain. Pain 2006 1.36
26 Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 2004 1.33
27 Visual analog scales for assessing surgical pain. J Am Coll Surg 2005 1.32
28 Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain 2008 1.32
29 Visceral and somatic hypersensitivity in a subset of rats following TNBS-induced colitis. Pain 2007 1.30
30 Cutaneous C-fiber pain abnormalities of fibromyalgia patients are specifically related to temporal summation. Pain 2008 1.22
31 The dynamic mechanisms of placebo induced analgesia: Evidence of sustained and transient regional involvement. Pain 2008 1.21
32 Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 2004 1.21
33 Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain 2005 1.19
34 Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 2009 1.18
35 Advanced continuous-contact heat pulse design for efficient temporal summation of second pain (windup). J Pain 2006 1.13
36 Revelation of a personal placebo response: its effects on mood, attitudes and future placebo responding. Pain 2007 1.10
37 Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain 2005 1.08
38 Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 2004 1.07
39 Altering gender role expectations: effects on pain tolerance, pain threshold, and pain ratings. J Pain 2003 1.07
40 Hypnosis modulates activity in brain structures involved in the regulation of consciousness. J Cogn Neurosci 2002 1.06
41 Characterizing individual differences in heat-pain sensitivity. Pain 2005 1.06
42 Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms. Pain 2003 1.05
43 Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine. Pain 2008 1.05
44 Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain 2010 1.04
45 Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep 2002 1.04
46 Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 2007 1.03
47 Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J Pain 2010 0.99
48 Patient-centered perspective on treatment outcomes in chronic pain. Pain Med 2009 0.99
49 Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain 2006 0.98
50 Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain 2010 0.96
51 Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain 2010 0.95
52 Spinal NMDA NR1 subunit expression following transient TNBS colitis. Brain Res 2009 0.95
53 Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes. J Pain 2012 0.93
54 Visceral and somatic hypersensitivity in TNBS-induced colitis in rats. Dig Dis Sci 2007 0.91
55 Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 2004 0.90
56 Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis. J Cell Mol Med 2012 0.88
57 Phosphorylation of NMDA NR1 subunits in the myenteric plexus during TNBS induced colitis. Neurosci Lett 2006 0.88
58 Patients' direct experiences as central elements of placebo analgesia. Philos Trans R Soc Lond B Biol Sci 2011 0.87
59 What is controlled for in placebo-controlled trials? Mayo Clin Proc 2005 0.87
60 Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome. Pain 2015 0.86
61 Attenuation of experimental pain by vibro-tactile stimulation in patients with chronic local or widespread musculoskeletal pain. Eur J Pain 2011 0.85
62 Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors. J Pain 2012 0.85
63 Mechanisms of acupuncture analgesia for clinical and experimental pain. Expert Rev Neurother 2006 0.84
64 Supra-threshold scaling, temporal summation, and after-sensation: relationships to each other and anxiety/fear. J Pain Res 2010 0.84
65 Effective connectivity among brain regions associated with slow temporal summation of C-fiber-evoked pain in fibromyalgia patients and healthy controls. J Pain 2012 0.84
66 Placebo manipulations reduce hyperalgesia in neuropathic pain. Pain 2012 0.84
67 An examination of the relationships among recalled, expected, and actual intensity and unpleasantness of delayed onset muscle pain. J Pain 2003 0.84
68 The effect of propofol on thermal pain perception. Anesth Analg 2005 0.82
69 Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials. Pain 2015 0.81
70 Appraisals of pain from controlled stimuli: relevance to quantitative sensory testing. Br J Health Psychol 2007 0.81
71 Heightened pain sensitivity in individuals with signs and symptoms of carpal tunnel syndrome and the relationship to clinical outcomes following a manual therapy intervention. Man Ther 2011 0.81
72 Functional connectivity of the default mode network and its association with pain networks in irritable bowel patients assessed via lidocaine treatment. J Pain 2013 0.81
73 Role of pain catastrophizing during pain processing in a cohort of patients with chronic and severe arthritic knee pain. Pain 2010 0.79
74 Representations of pain in the brain. Curr Rheumatol Rep 2004 0.79
75 Sex differences in common pain events: expectations and anchors. J Pain 2003 0.77
76 Do past pain events systematically impact pain ratings of healthy subjects or fibromyalgia patients? J Pain 2009 0.77
77 Placebo analgesia: widening the scope of measured influences. Pain 2009 0.77
78 Hypnosis phenomenology and the neurobiology of consciousness. Int J Clin Exp Hypn 2003 0.77
79 The Relationship between Marital Status and Psychological Resilience in Chronic Pain. Pain Res Treat 2013 0.76
80 Reply to commentary. J Pain 2013 0.75
81 Importance of Measuring Placebo Factors in Complex Clinical Trials. Pain 2008 0.75
82 Role of Placebo Factors in Clinical Trials with Special Focus on Enrichment Designs. Pain 2008 0.75
83 New facts and improved ethical guidelines for placebo analgesia. J Pain 2005 0.75
84 Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain. Pain 2017 0.75